Walgreens Boots Alliance, Inc. $WBA Shares Sold by Aberdeen Group plc

Key Points

• Aberdeen Group plc reduced its holdings in Walgreens Boots Alliance by 53.0% in the first quarter, selling 171,920 shares and now owning 152,525 shares valued at approximately $1.7 million.
• Walgreens Boots Alliance reported $0.38 EPS for the last quarter, surpassing the expected $0.34, with a revenue of $38.99 billion compared to the forecast of $36.72 billion.
• The company's stock has seen a 52-week range between $8.08 and $13.25, with a market capitalization of $10.55 billion.

Aberdeen Group plc reduced its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 53.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 152,525 shares of the pharmacy operator's stock after selling 171,920 shares during the quarter. Aberdeen Group plc's holdings in Walgreens Boots Alliance were worth $1,703,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of WBA. Colonial Trust Co SC increased its stake in Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,297 shares in the last quarter. Sentry Investment Management LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter valued at approximately $27,000. Curat Global LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter valued at approximately $27,000. Federated Hermes Inc. increased its stake in Walgreens Boots Alliance by 135.8% in the 1st quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock valued at $35,000 after purchasing an additional 1,815 shares in the last quarter. Finally, N.E.W. Advisory Services LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter valued at approximately $43,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

Walgreens Boots Alliance stock opened at $12.19 on Friday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.32 and a current ratio of 0.60. The stock has a fifty day moving average of $11.62 and a two-hundred day moving average of $11.16. The company has a market capitalization of $10.55 billion, a price-to-earnings ratio of -1.67, a PEG ratio of 1.43 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.04. The company had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%.Walgreens Boots Alliance's revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.63 earnings per share. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on WBA. UBS Group reaffirmed a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Wall Street Zen began coverage on Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a "hold" rating for the company. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Two research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Reduce" and an average price target of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.